Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.
about
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityrAGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AMLImproving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.The emerging role of radioimmunotherapy in haematological malignancies.177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice.Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.Biodistribution and dosimetry of (177)Lu-tetulomab, a new radioimmunoconjugate for treatment of non-Hodgkin lymphomaAnti-CD37 antibodies for chronic lymphocytic leukemia.Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma.A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies.Targeting of tetraspanin proteins--potential benefits and strategiesStandard Operating Procedure for Prospective Individualised Dosimetry for ([131])I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma.Epratuzumab in the therapy of oncological and immunological diseases.A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy.Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies.A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemiaRecombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy.Using antibodies to target cancer therapeutics.Radioimmunotherapy in mantle cell lymphoma.Targeting tetraspanins in cancer.Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.Radioimmunotherapy of solid cancers: A review.An approach for conjugation of (177) Lu- DOTA-SCN- Rituximab (BioSim) & its evaluation for radioimmunotherapy of relapsed & refractory B-cell non Hodgkins lymphoma patients.Investigational therapies targeting CD37 for the treatment of B-cell lymphoid malignancies.Monoclonal antibodies in the treatment of human B-cell malignancies.Radioimmunotherapy for Non-Hodgkin's Lymphoma.
P2860
Q24681992-BACB99D5-4150-41E9-95A0-3E98294ED720Q26776480-1F566161-63E8-4313-814C-64442A555117Q30403563-BBED2518-2296-4909-AA69-5A7CFE6653E8Q33645793-D8E47D35-70FC-4444-A6C1-246857C2BDD6Q33904384-EFF4DE0C-8392-4413-9C79-5C1852AFE37AQ33961370-10C4C47B-C0BD-458C-A865-6B88677A6A5EQ34122286-41520786-E57B-43C6-B5A6-3D8E5F81C3E5Q34318792-9AC60611-11A6-45E1-AC7B-689D701C0483Q34405641-5B88A747-B7D8-4C4B-BA1C-DC011CF0783DQ34480345-FFA852DF-3E0E-4A94-A0A6-57115E6FF11FQ35483665-C70D3BCD-8378-4072-82EE-BD7F5163DB22Q36533706-5E1CB4A9-C810-4564-BB71-3E871B347A0BQ36563416-FC80F5DB-328B-476C-A8E3-E90E272DA9C1Q36636619-2001AEA3-72CC-4C7C-B081-FA52B18DC8FAQ37169112-952C2302-A10E-4370-B0FE-D5C2EFA57A6AQ37364355-061C7788-AF20-4616-AF7C-AF0CFCBADF7FQ37609420-1F2A0EC6-F687-4C13-BF04-2284E8F80C05Q37720857-F5E28A76-4F6A-4A8A-9F29-7ED23D96BD79Q38014920-B73AEDA2-D7DA-4461-981F-E35327315EB8Q38017790-27E38C4D-E0F4-4D3B-A75E-8C807795E373Q38033584-06F0C1D6-C75F-4EF7-AB44-1EAA49B3F3F7Q38795442-AA1EC64D-E898-48AC-A61E-46B2713FC77FQ41014974-EE71AA5B-2F70-4C59-B7DD-DD5CA8D447CEQ41760763-47F6678C-BAA3-48B7-94E0-3CF9F7D7CE51Q48541938-FEA1DCF1-D875-4B8D-A16E-86D87BF3D477Q51092788-08AD5FAF-28A5-47A7-8DCF-5A7006635111Q55041225-750A068F-DE60-4BBA-ABFD-DFF286FBCA2C
P2860
Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Imaging, dosimetry, and radioi ...... 7 antibody in B-cell lymphoma.
@ast
Imaging, dosimetry, and radioi ...... 7 antibody in B-cell lymphoma.
@en
type
label
Imaging, dosimetry, and radioi ...... 7 antibody in B-cell lymphoma.
@ast
Imaging, dosimetry, and radioi ...... 7 antibody in B-cell lymphoma.
@en
prefLabel
Imaging, dosimetry, and radioi ...... 7 antibody in B-cell lymphoma.
@ast
Imaging, dosimetry, and radioi ...... 7 antibody in B-cell lymphoma.
@en
P2093
P1476
Imaging, dosimetry, and radioi ...... 7 antibody in B-cell lymphoma.
@en
P2093
C A Hanson
D P Normolle
I R Francis
K R Zasadny
M S Kaminski
R B DelRosario
P304
P356
10.1200/JCO.1992.10.11.1696
P407
P577
1992-11-01T00:00:00Z